Result of AGM

GenIP PLC

24 June 2026

 

24 June 2026

GenIP Plc

("GenIP" or the "Company")

Result of AGM

GenIP Plc (AIM: GNIP), a technology consultancy providing AI-driven services to help research organisations and corporations commercialise their innovations, is pleased to announce that at the Company's Annual General Meeting ("AGM") held earlier today all resolutions were duly passed.

The number of votes cast for and against each of the resolutions proposed, and the number of votes withheld were as follows:

Resolution	For	% Votes Cast	Against	% Votes Cast	Votes Withheld	Total Votes Cast
(1)     Approval of the Annual Report and Accounts	13,034,359	99.95	6,657	0.05	1,000	13,041,016
(2)    Re-appoint HW Fisher LLP as auditor of the Company	13,013,071	99.79	27,945	0.21	1,000	13,041,016
(3)    Authorise the Directors to determine the auditor's remuneration	12,884,866	98.8	156,150	1.2	1,000	13,041,016
(4)    Re-elect Lord David Willetts as a Director of the Company	12,634,053	97.23	359,960	2.77	48,003	12,994,013
(5)    Re-elect Melissa Cruz as a Director of the Company	12,706,872	97.79	287,141	2.21	48,003	12,994,013
(6)    Re-elect Kevin Fitzpatrick as a Director of the Company	12,634,053	97.23	359,960	2.77	48,003	12,994,013
(7)    Re-elect Professor David Gann CBE as a Director of the Company	12,706,872	97.79	287,141	2.21	48,003	12,994,013
(8)    To authorise the Directors to allot shares, up to an aggregate nominal amount equal to £54,224.60	12,634,105	96.89	405,908	3.11	2,003	13,040,013
(9)    To authorise the Directors to disapply pre-emption rights in respect of a rights issue and otherwise up to an aggregate nominal amount equal to £54,224.60	12,634,105	96.89	405,908	3.11	2,003	13,040,013

1.     Proxy appointments which gave discretion to the Chairman of the AGM have been included in the "For" total for the appropriate resolution.

2.     Votes "For" and "Against" any resolution are expressed as a percentage of votes validly cast for that resolution.

3.     A "Vote withheld" is not a vote in law and is not counted in the calculation of the percentage of shares voted "For" or "Against".

4.     The full text of the resolutions passed at the AGM can be found in the Notice of Annual General Meeting which is available on the Company's website at http://genip.ai/.

As at 24 June 2026, there were 25,517,461 ordinary shares in issue. Shareholders are entitled to one vote per share.

Votes withheld are not votes in law and so have not been included in the calculation of the proportion of votes for and against a resolution.

For further information regarding GenIP, please visit www.genip.ai, or contact:

GenIP Plc Melissa Cruz, CEO		Via Redchurch Communications
Beaumont Cornish Limited (Nominated Adviser) Roland Cornish / Asia Szusciak / Andrew Price		Tel:  [phone]
AlbR Capital Limited (Broker)  Colin Rowbury Jon Belliss		Tel: [phone] [e-mail]  [e-mail]
CMC Markets (Joint Broker)		Tel: + 44 (0) 203 003 8632
Douglas Crippen
Redchurch Communications (Financial PR) John Casey		[e-mail]

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

Notes to Editors

About GenIP

GenIP is a next-generation business      at the intersection of generative AI and innovation strategy. We empower corporates, venture funds, and research institutions to evaluate, commercialise, and scale breakthrough technologies. By combining proprietary GenAI algorithms with expert human analysis, GenIP delivers decision-grade insights and talent solutions that accelerate innovation outcomes.

Service Offerings

GenIP operates through two synergistic service lines:

Service	Description	Value Proposition
Invention Intelligence Product Suite	AI-powered market intelligence reports assessing the commercial potential of emerging technologies	Enables faster, evidence-based decisions on R&D prioritisation, investment, and IP strategy
IP Commercialization Services	End-to-end engagement to help research organisations commercialise innovations	Provides cost-effective, broad support to achieve our clients' strategic objectives

Together, these services form a unified GenAI-enabled platform for innovation triage and execution.

Vision & Strategy

GenIP aims to become the global leader in generative AI analytics for innovation commercialisation. Our strategy is anchored in three growth pillars:

●     Organic Expansion
Scale Invention Evaluator and Recruitment Services through targeted outreach to corporates, VCs, and research institutions, supported by strategic marketing and digital engagement.

●     Service Deepening
Enhance functionality and margin by expanding GenAI capabilities within both service lines-unlocking new use cases and customer segments.

●     Strategic Acquisitions
Pursue bolt-on acquisitions of complementary GenAI services with validated market traction to broaden our offering and accelerate growth.

Forward looking statements

Certain statements contained in this announcement constitute forward-looking statements. When used in this announcement, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "seek", "propose", "estimate", "expect", and similar expressions, as they relate to the Company, are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding intentions, beliefs or current expectations concerning, among other things, the Company's results of operations, financial position, liquidity, prospects, growth, strategies and expectations of the industry in which the Company operates.

Such statements reflect the Company's current views with respect to future events and are subject to certain risks, uncertainties and assumptions. Many factors could cause the Company's actual results, performance or achievements to materially differ from those described in this announcement Should one or more of these risks or uncertainties materialise, or should assumptions underlying forward-looking statements prove incorrect, actual results may differ materially from those described in this announcement as "intended", "planned", "anticipated", "believed", "proposed", "estimated" or "expected".

For the avoidance of doubt, the contents of the Company's website and any hyperlinks accessible from the Company's website are not incorporated by reference into, and do not form part of, this announcement and investors should not rely on them.

-ENDS-

 

END